Abstract: From 1963 to the present, many reviews of antimalarials for use in dermatology have mentioned the speeial sensitivity of ehildren to these drugs. Fatal reactions have been limited to aeeidental or intentional overdosage and two instanees of IM injection. While 1 gni of ehloroquine ean produee fatal reaetion in very young ehildren. analysis of published and unpublished eases show that adults exhibit a similar sensitivity when eompared on a mg/kg basis. This information should eneourage a physician to use antimalarials where appropriate, but speeial precaution should be taken to prevent poisoning.
Antimalarials (AM) are not commonly used in thc treatment of children with skin disease. There are, however, several situations in which AM may be most useful (1) (2) (3) (4) (5) (6) . Isaacson. Elgart. and Turner list over 15 conditions in which antimalarials may be of some therapeutic benefit (3) . Of these, discoid lupus er\thematosus and polymorphus light eruption oecur with some frequency in ehildren. In addition. Isaacson et ak note that antimalarials have been anecdotally reported to be effective in scleroderma. disseminated granuloma annulare. sarcoid and epidermolysis buUosa. conditions that are aiso seen occasionally in the pediatrie population. There are. of course, other nondermatologic conditions for which antimalarials play a substantial part in therapy. There are numerous reviews attesting to the efficacy of antimalarials in the treatment of rheumatoid atlhritis. Antimalarials are still recommended for the prophylaxis and treatment of malaria for both travelers and those who are indigenous to the malaria belts of the world (7). In addition, many authors consider quinacrine to be the treatment of choice for giardiasis, whieh is a not uncommon enteric parasitic infection of ehildren and young adults (8. 9) . Finally, the optical isomer of quinine-quinidinc-is occasionally used for the treatment of cardiac arrhythmias in children (10) .
Although I do not use antimalarials commonly in my pediatric practice. I was aware that there are definite indications for their use in the population and have prescribed them many times without significant adverse reaction. Consequently I have been surprised to read, during the past four years, that many authors consider antimalarials eontraindicated in the treatment of children with skin disease (1) (2) (3) (4) (5) (6) . Four reviews in the past two years mentioned that antimalarials are exceptionally toxic in children (3) (4) (5) (6) , and two of them have concluded that these drugs are contraindicated tor use in this population (3, 6) . I was even more surprised to find that this position was not a new one, but had been mentioned in reviews of antimalarials sinee 1963. At that time, Rees and Maibach noted that choloroquine vvas exceptionally toxic in children and that deaths had occurred from as little as 7? mg (I). In addition. Sams in his 1976 review of antimalarials came to a similar conclusion, suggesting that they are contraindicated in children (2) .
Because of this paradox-many dermatologists considering antimalarials contraindicated, but other physicians using them for parasitic diseases, rheumatoid arthritis, and a diversity of cutaneous conditions, etc.-I conducted a literature review on this subject and present these results to you. There is no evidence suggesting that children have an increased incidence of subacute and chronic toxicity for antimalarials. Nearly all reports focus on accidental or intentional overdosage. Cann and Verhulst were the first to report fatal poisonings from antimalarials in ehildren (II). These 3 fatal cases occurred in 1-3-year-old children who had taken approximately 1-3.5 grams of ehloroquine orally. Toxic symptoms appeared 1 to 3 hours later and eonsisted of convulsions, apnea, and eardiae arrest. Similar groups of 1-2 ehildren contmued to be published during the mid and late 1960s (12) (13) (14) (15) . Most ofthe poisonings were due to ehloroquine. but at least one occurred after the oral ingestion of quinine (15) . In 1974. DeMaio and Henry published a general review of ehloroquine poisoning (16) years. In 3 ol the cases, the amount (jt thc drug ingested was unknown, and in the other 3 it ranged trom 1 to 2.5 grams. The data available for toxic reactions in the adults in this series indicated that they succumbed lo a dose ranging from as few as 10 ehloroquine tablets, to approximately 50. Based on Ihis information, the authors conclude that "children . . . appear to be especially sensitive to this drug," If. however, the number of tablets necessary to produce a toxic reaction in children is compared to that of adults on a tablet or mg/kg basis, then this disparity ceases to exist. A 2-year-old child (average weight 14 kilograms) succumbed to I gm of chloroquine for a lethal dose of 70 mg/kg. while a minimum of ten 500 mg tablets was needed to produce a fatal result in adult servicemen (average weight 80 kilograms) for a lethal dose of 60 mg/kg.
From 1974 until the present time, poisonings frotn antimalarials continue to he reported, usually from accidental or intentional overdosage (12) (13) (14) (15) (16) (17) (18) (19) . There are, however, two examples where ehloroquine had been used therapeutically with a fatal outcome (19) (20) . These reports described the intramuscular itijeetion of ehloroquine for the treatment of maiaria in very young ehildren.
In addition to these published case reports, there are 4 unpublished reports contained in the FDA's toxicology files (21) . In these situations, the patientr anged in age from 2 to 17 years, with a minimum toxie dose being 2 gm of ehloroquine. One patienl in this series was 17 years of age and took an unknown number of hydroxychloroquine tablets.
There are certainly many more examples of toxiv reaction to orally ingested antimalarials. but these patients are usually blended in with general reviewô f poisoning (22, 23) . Specific data about drug dose age of the patient, etc. are usually not given.
Toxic reactions to antimalarials occur quite rapidly after overdose. In pan. this is because this group of dtngs is rapidly and completely absorbed in the upper portion of the gastrointestinal tract. Nausea and vomiting are common early symptoms and are also seen commonly in children and adults who ha\e taken otherwise safe, therapeutie doses. Several studies suggest that younger children are more su>-ceptable to gastric itTitation from antimalarials thar, are older children (7. 24). More advanced cases ol poisoning resemble examples of salicylism with tinnitus and vertigo being common symptoms. As poisoning progresses, generalized seizures occur, followed by cardiac and respiratory arrest. Apparently the fatal etTects ol" AM are in major part related to their ability to depress myoeardial exeitability.
There is no specific antidote for antimalarial overdose, but immediate gastric emesis and lavage would seetn most appropriate. Peritoneal dialysis has been used in one childhood poisoning, but without pronotinccd beneficial effect ( 18) ,
